Report overview
The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms.
This report aims to provide a comprehensive presentation of the global market for Veterinary Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Autogenous Vaccines. This report contains market size and forecasts of Veterinary Autogenous Vaccines in global, including the following market information:
Global Veterinary Autogenous Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Autogenous Vaccines Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Veterinary Autogenous Vaccines companies in 2022 (%)
The global Veterinary Autogenous Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pet Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Autogenous Vaccines include ZOETIS, Ceva Biovac, Boehringer Ingelheim, Gallant Custom Laboratories, UVAXX, Bimeda, Dyntec, Elanco Animal Health and Vaxxinova, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Autogenous Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Autogenous Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, by Type, 2022 (%)
Pet Vaccine
Livestock Vaccine
Global Veterinary Autogenous Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, by Application, 2022 (%)
Research Facility
Pet Clinic
Ranches
Others
Global Veterinary Autogenous Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Autogenous Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Autogenous Vaccines revenues share in global market, 2022 (%)
Key companies Veterinary Autogenous Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Veterinary Autogenous Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ZOETIS
Ceva Biovac
Boehringer Ingelheim
Gallant Custom Laboratories
UVAXX
Bimeda
Dyntec
Elanco Animal Health
Vaxxinova
Hygieia Biological Laboratories
Deltamune Animal Health
Genova Labs
Newport Laboratories
Epitopix
LOHMANN TIERZUCHT
Addison Biological Laboratory
Phibro Animal Health Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Autogenous Vaccines, market overview.
Chapter 2: Global Veterinary Autogenous Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Autogenous Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
